|
The Immunohistochemistry Antibody Company
|
- Home
-
Products
- All Antibodies
- IHC-plus Antibodies
-
Services
- Immunohistochemistry Studies
- Tissue Cross-Reactivity Screening
- Distributors
-
Resources
- About our Tissue Bank
- Customer Support
- How to Buy
- IHC-plus Protocol
- LSBio Media
- Publications
- Antibody Reports
-
Company
- About LifeSpan
- Press Releases
- Holiday Schedule
- Contact Us
|
|
General Cancer Screen 60 Tissue Microarray - LS-SCA60
This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.
|
|
| Catalog ID: |
LS-SCA60 |
| Product Name: |
General Cancer Screen 60 |
| Description: |
Various cancers (12 common types) with unmatched adjacent normal/non-neoplastic specimens |
| Format: |
FFPE |
| Category: |
Human Tumor and Adjacent Normal |
| QA/QC: |
H&E reviewed; IHC validated with a positive control antibody |
| Storage: |
Short term RT; Long term 4ºC |
| Clinical History: |
No |
| Tissue Marker: |
No |
| Stage/Grade: |
Yes |
| Core Diameter: |
1.5 mm |
| Core Thickness: |
5 µm |
| Cases: |
71 |
| Cores: |
72 |
| Slides Per Set: |
1 |
LS-SCA60 Tissue Microarray Map
Slide Number 1
| LABEL | | | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | | A | Eso | Eso | Eso | Sto | Sto | Sto | Col | Col | Col | | B | Eso | Eso | Eso | Sto | Sto | Sto | Col | Col | Col | | C | Rec | Rec | Rec | Liv | Liv | Liv | Lng | Lng | Lng | | D | Rec | Rec | Rec | Liv | Liv | Liv | Lng | Lng | Lng | | E | Kid | Kid | Kid | Bst | Bst | Bst | Cvx | Cvx | Cvx | | F | Kid | Kid | Kid | Bst | Bst | Bst | Cvx | Cvx | Cvx | | G | Ova | Ova | Ova | Pst | Pst | Pst | Pnc | Pnc | Pnc | | H | Ova | Ova | Ova | Pst | Pst | Pst | Pnc | Pnc | Pnc |
|
Diagnosis Type Legend| Benign non-neoplastic | Diseased | Inflammatory | Malignant | Metastatic | Tumor | Unknown |
Element Tissue LegendBreast (Bst); Cervix (Cvx); Colon (Col); Colon, Mucosa (Col); Esophagus (Eso); Kidney (Kid); Liver (Liv); Lung (Lng); Ovary (Ova); Pancreas (Pnc); Prostate (Pst); Rectum (Rec); Stomach (Sto); Stomach, Body (Sto);
LS-SCA60 Element Details
| Slide | Position | Species | Gender | Age | Tissue | Diagnosis | Diagnosis Type | Tumor Grade |
|---|
| 1 | A1 | Human | M | 62 y | Esophagus (Eso) | Squamous cell carcinoma | Malignant | Grade II |
| 1 | A2 | Human | M | 56 y | Esophagus (Eso) | Squamous cell carcinoma | Malignant | Grade II-III |
| 1 | A3 | Human | F | 72 y | Esophagus (Eso) | Squamous cell carcinoma | Malignant | |
| 1 | A4 | Human | F | 55 y | Stomach (Sto) | Adenocarcinoma | Malignant | Grade III |
| 1 | A5 | Human | M | 56 y | Stomach (Sto) | Adenocarcinoma | Malignant | Grade II |
| 1 | A6 | Human | M | 74 y | Stomach (Sto) | Adenocarcinoma | Malignant | Grade III |
| 1 | A7 | Human | M | 37 y | Colon (Col) | Adenocarcinoma | Malignant | Grade II |
| 1 | A8 | Human | M | 82 y | Colon (Col) | Adenocarcinoma | Malignant | Grade I |
| 1 | A9 | Human | M | 58 y | Colon, Mucosa (Col) | Adjacent normal with chronic inflammation | Inflammatory | |
| 1 | B1 | Human | M | 38 y | Esophagus (Eso) | Normal | Benign non-neoplastic | |
| 1 | B2 | Human | F | 72 y | Esophagus (Eso) | Normal | Benign non-neoplastic | |
| 1 | B3 | Human | M | 53 y | Esophagus (Eso) | Normal | Benign non-neoplastic | |
| 1 | B4 | Human | M | 54 y | Stomach, Body (Sto) | Normal | Benign non-neoplastic | |
| 1 | B5 | Human | M | 54 y | Stomach, Body (Sto) | Normal | Benign non-neoplastic | |
| 1 | B6 | Human | M | 48 y | Stomach, Body (Sto) | Normal | Benign non-neoplastic | |
| 1 | B7 | Human | F | 56 y | Colon (Col) | Normal | Benign non-neoplastic | |
| 1 | B8 | Human | F | 70 y | Colon (Col) | Normal | Benign non-neoplastic | |
| 1 | B9 | Human | M | 40 y | Colon (Col) | Normal | Benign non-neoplastic | |
| 1 | C1 | Human | M | 55 y | Rectum (Rec) | Adenocarcinoma | Malignant | Grade II |
| 1 | C2 | Human | M | 67 y | Rectum (Rec) | Adenocarcinoma | Malignant | Grade II |
| 1 | C3 | Human | F | 55 y | Rectum (Rec) | Adenocarcinoma | Malignant | Grade II |
| 1 | C4 | Human | F | 32 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | Grade III |
| 1 | C5 | Human | M | 39 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | Grade II |
| 1 | C6 | Human | F | 55 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | Grade II |
| 1 | C7 | Human | M | 66 y | Lung (Lng) | Squamous cell carcinoma | Malignant | Grade II-III |
| 1 | C8 | Human | F | 59 y | Lung (Lng) | Squamous cell carcinoma | Malignant | Grade II-III |
| 1 | C9 | Human | M | 55 y | Lung (Lng) | Squamous cell carcinoma | Malignant | Grade II-III |
| 1 | D1 | Human | F | 43 y | Rectum (Rec) | Normal | Benign non-neoplastic | |
| 1 | D2 | Human | M | 33 y | Rectum (Rec) | Normal | Benign non-neoplastic | |
| 1 | D3 | Human | M | 67 y | Rectum (Rec) | Normal | Benign non-neoplastic | |
| 1 | D4 | Human | M | 63 y | Liver (Liv) | Normal with fatty degeneration | Diseased | |
| 1 | D5 | Human | M | 55 y | Liver (Liv) | Normal | Benign non-neoplastic | |
| 1 | D6 | Human | M | 56 y | Liver (Liv) | Normal | Benign non-neoplastic | |
| 1 | D7 | Human | M | 73 y | Lung (Lng) | Normal | Benign non-neoplastic | |
| 1 | D8 | Human | F | 68 y | Lung (Lng) | Normal | Benign non-neoplastic | |
| 1 | D9 | Human | M | 65 y | Lung (Lng) | Normal | Benign non-neoplastic | |
| 1 | E1 | Human | M | 70 y | Kidney (Kid) | Clear cell carcinoma | Malignant | Grade I-II |
| 1 | E2 | Human | M | 46 y | Kidney (Kid) | Clear cell carcinoma | Malignant | Grade I-II |
| 1 | E3 | Human | M | 54 y | Kidney (Kid) | Clear cell carcinoma | Malignant | Grade I |
| 1 | E4 | Human | F | 29 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | Grade I-II |
| 1 | E5 | Human | F | 51 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | Grade II |
| 1 | E6 | Human | F | 63 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | Grade II-III |
| 1 | E7 | Human | F | 76 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | Grade III |
| 1 | E8 | Human | F | 47 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | Grade II |
| 1 | E9 | Human | F | 42 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | Grade II |
| 1 | F1 | Human | M | 54 y | Kidney (Kid) | Normal | Benign non-neoplastic | |
| 1 | F2 | Human | M | 56 y | Kidney (Kid) | Normal | Benign non-neoplastic | |
| 1 | F3 | Human | F | 47 y | Kidney (Kid) | Normal | Benign non-neoplastic | |
| 1 | F4 | Human | F | 43 y | Breast (Bst) | Normal | Benign non-neoplastic | |
| 1 | F5 | Human | F | 43 y | Breast (Bst) | Normal | Benign non-neoplastic | |
| 1 | F6 | Human | F | 41 y | Breast (Bst) | Normal | Benign non-neoplastic | |
| 1 | F7 | Human | F | 32 y | Cervix (Cvx) | Normal | Benign non-neoplastic | |
| 1 | F8 | Human | F | 39 y | Cervix (Cvx) | Normal | Benign non-neoplastic | |
| 1 | F9 | Human | F | 20 y | Cervix (Cvx) | Normal | Benign non-neoplastic | |
| 1 | G1 | Human | F | 56 y | Ovary (Ova) | Cystadenocarcinoma, Serous | Malignant | Grade III |
| 1 | G2 | Human | F | 49 y | Ovary (Ova) | Cystadenocarcinoma, Serous | Malignant | Grade II-III |
| 1 | G3 | Human | F | 59 y | Ovary (Ova) | Cystadenocarcinoma, Serous | Malignant | Grade III |
| 1 | G4 | Human | M | 81 y | Prostate (Pst) | Adenocarcinoma | Malignant | 3 |
| 1 | G5 | Human | M | 51 y | Prostate (Pst) | Adenocarcinoma | Malignant | 4-5 |
| 1 | G6 | Human | M | 70 y | Prostate (Pst) | Adenocarcinoma | Malignant | 4 |
| 1 | G7 | Human | F | 75 y | Pancreas (Pnc) | Ductal adenocarcinoma | Malignant | Grade II |
| 1 | G8 | Human | M | 65 y | Pancreas (Pnc) | Ductal adenocarcinoma | Malignant | Grade II-III |
| 1 | G9 | Human | M | 55 y | Pancreas (Pnc) | Ductal adenocarcinoma | Malignant | Grade II |
| 1 | H1 | Human | F | 53 y | Ovary (Ova) | Normal | Benign non-neoplastic | |
| 1 | H2 | Human | F | 39 y | Ovary (Ova) | Normal | Benign non-neoplastic | |
| 1 | H3 | Human | F | 31 y | Ovary (Ova) | Normal | Benign non-neoplastic | |
| 1 | H4 | Human | M | 63 y | Prostate (Pst) | Normal | Benign non-neoplastic | |
| 1 | H5 | Human | M | 52 y | Prostate (Pst) | Normal | Benign non-neoplastic | |
| 1 | H6 | Human | M | 48 y | Prostate (Pst) | Normal | Benign non-neoplastic | |
| 1 | H7 | Human | M | 51 y | Pancreas (Pnc) | Normal | Benign non-neoplastic | |
| 1 | H8 | Human | M | 40 y | Pancreas (Pnc) | Normal | Benign non-neoplastic | |
| 1 | H9 | Human | F | 38 y | Pancreas (Pnc) | Normal | Benign non-neoplastic | |
Copyright © 2013 LifeSpan BioSciences, Inc. All Rights Reserved
